Status:
TERMINATED
Kidney Damage In Patients With Severe Fall In eGFR
Lead Sponsor:
Bracco Diagnostics, Inc
Conditions:
Coronary Artery Stenosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is a pilot study using a randomized, double blinded, comparison of two iodinated contrast agents used during percutaneous coronary intervention (PCI). All patients enrolled must have and estimate...
Eligibility Criteria
Inclusion
- Provides written Informed Consent
- Is at least 18 years of age;
- Is scheduled for or likely to undergo percutaneous coronary intervention;
- Has documented estimated glomerular filtration rate \[eGFR\] \< 30 mL/min/1.73 m2 calculated with the MDRD formula within 72 hours prior the enrolment.
Exclusion
- Is a pregnant or lactating female
- Has a history of severe congestive heart failure
- Has a history of hyperthyroidism
- Has unstable renal function
- Has a history of hypersensitivity to iodinated contrast agents
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01136915
Start Date
November 1 2010
End Date
November 1 2012
Last Update
March 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institu De Cardiologie De Montreal
Montreal, Quebec, Canada